Metabolism News and Research

Latest Metabolism News and Research

Study: About 42% of screened veterans with blast injuries have irregular hormone levels

Up to 20 percent of veterans returning from Afghanistan and Iraq have experienced at least one blast concussion. New research suggests that nearly half these veterans may have a problem so under-recognized that even military physicians may fail to look for it.

23 Apr 2013

Findings open new possibilities for research, testing treatments to combat obesity

Joslin scientists report significant findings about the location, genetic expression and function of human brown adipose tissue and the generation of new BAT cells.

23 Apr 2013

Janssen Diabetes Forum: A medical education initiative for management of type 2 diabetes

Launched today in Beerse, the Janssen Diabetes Forum (www.janssendiabetesforum.com) is a novel medical education initiative, which has been developed to contribute to the understanding of the latest developments in the management of type 2 diabetes.

22 Apr 2013

Investigator honored for advancing osteoporosis research and advocacy worldwide

Professor Socrates Papapoulos, a long standing member of the IOF Board and leading researcher at the Leiden University Medical Center, has been named the recipient of the prestigious Pierre Delmas Award.

22 Apr 2013

Aurigene and Endo’s collaborative efforts yield novel drug candidates

Aurigene and Endo entered into collaboration in 2009, for multiple integrated drug discovery programs in the areas of Inflammation and Oncology.

22 Apr 2013

Non-invasive brain surgery: an interview with Dr Andres Lozano, University of Toronto

MR-guided focused ultrasound is a new technique that involves focusing 1024 beams of ultrasound through the skull to a focal point in the brain, very much like using the sun and a magnifying glass to burn a hole in a sheet of paper.

22 Apr 2013

Study identifies potential drug targets that interfere with cancer metabolism

A massive study analyzing gene expression data from 22 tumor types has identified multiple metabolic expression changes associated with cancer.

22 Apr 2013

AACE publishes comprehensive diabetes management algorithm to treat prediabetes, T2DM patients

The American Association of Clinical Endocrinologists today announced the publication of its comprehensive diabetes management algorithm created to guide primary care physicians, endocrinologists and other health care professionals in the treatment of prediabetes and type 2 diabetes mellitus patients.

20 Apr 2013

Combination therapies may advance treatment for anaplastic thyroid cancer

A combination of therapies may prove to be a promising advance for the treatment of anaplastic thyroid cancer based on results of a phase I clinical trial, say researchers at Mayo Clinic in Florida.

19 Apr 2013

Research shows how breakdowns in DNA copying process contribute to cancer

Research led by a scientist at the University of York has thrown new light on the way breakdowns in the DNA copying process inside cells can contribute to cancer and other diseases.

19 Apr 2013

Excess glutamate drives schizophrenia in high-risk individuals

An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people who are at risk for schizophrenia, reports a study from investigators at Columbia University Medical Center published in the current issue of Neuron.

19 Apr 2013

University of Florence professor awarded ESCEO-IOF Servier Pierre D. Delmas Prize

Today, at the opening of the European Congress on Osteoporosis & Osteoarthritis in Rome, Italy, Professor Maria Luisa Brandi MD, Professor of Endocrinology and Metabolic Diseases at the University of Florence, Florence, Italy was presented with ESCEO-IOF Servier Pierre D. Delmas Prize.

18 Apr 2013

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

Scientists from academic institutions reported at the 2013 annual American Association for Cancer Research meeting, results from preclinical studies which showed that certain bladder cancers and mesotheliomas have metabolic changes and are more likely to respond to treatment with ADI-PEG 20 (pegylated arginine deiminase) if they are deficient in the enzyme, argininosuccinate synthetase.

18 Apr 2013

UTMB researchers identify protein that can interfere with the brain's response to leptin

Ever since the appetite-regulation hormone called leptin was discovered in 1994, scientists have sought to understand the mechanisms that control its action. It was known that leptin was made by fat cells, reduced appetite and interacted with insulin , but the precise molecular details of its function -details that might enable the creation of a new treatment for obesity - remained elusive.

18 Apr 2013

Researchers report progress on non-invasive method to assess kidney function

Researchers may have found a way to block kidney-destroying inflammation and help damaged kidney cells recover.

17 Apr 2013

L-carnitine improves cardiac health in patients after heart attack, say researchers

L-carnitine significantly improves cardiac health in patients after a heart attack, say a multicenter team of investigators in a study published today in Mayo Clinic Proceedings.

15 Apr 2013

Obesity epidemic in the Asia Pacific region: an interview with Prof Drexel, European Society of Cardiology

The prevalence of obesity is about 20 % in Australia, 17 % in Japan, but only 3 – 4 % in China. Thus, Asia Pacific is a very heterogeneous region.

15 Apr 2013

Researchers identify new potential therapeutic target for lowering cholesterol

Researchers at the University of Michigan have identified a new potential therapeutic target for lowering cholesterol that could be an alternative or complementary therapy to statins.

12 Apr 2013

Protein EPAC2 plays major role in development of type 2 diabetes

A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly 26 million people in the United States alone and counts as one of the leading causes of heart disease, stroke and kidney, eye and nerve damage.

12 Apr 2013

Migraine severity and adiponectin: an interview with Dr. B. Lee Peterlin, Johns Hopkins University School of Medicine

Migraine affects an estimated 30 million people in the U.S, with the one year prevalence of migraine estimated at 12% of the general population, including 18% of all women and 6% of all men.

12 Apr 2013

Metabolism News and Research

Latest Metabolism News and Research

Study: About 42% of screened veterans with blast injuries have irregular hormone levels

Findings open new possibilities for research, testing treatments to combat obesity

Janssen Diabetes Forum: A medical education initiative for management of type 2 diabetes

Investigator honored for advancing osteoporosis research and advocacy worldwide

Aurigene and Endo’s collaborative efforts yield novel drug candidates

Non-invasive brain surgery: an interview with Dr Andres Lozano, University of Toronto

Study identifies potential drug targets that interfere with cancer metabolism

AACE publishes comprehensive diabetes management algorithm to treat prediabetes, T2DM patients

Combination therapies may advance treatment for anaplastic thyroid cancer

Research shows how breakdowns in DNA copying process contribute to cancer

Excess glutamate drives schizophrenia in high-risk individuals

University of Florence professor awarded ESCEO-IOF Servier Pierre D. Delmas Prize

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

UTMB researchers identify protein that can interfere with the brain's response to leptin

Researchers report progress on non-invasive method to assess kidney function

L-carnitine improves cardiac health in patients after heart attack, say researchers

Obesity epidemic in the Asia Pacific region: an interview with Prof Drexel, European Society of Cardiology

Researchers identify new potential therapeutic target for lowering cholesterol

Protein EPAC2 plays major role in development of type 2 diabetes

Migraine severity and adiponectin: an interview with Dr. B. Lee Peterlin, Johns Hopkins University School of Medicine

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging